Skip to main content
. 2016 Apr 4;34(15):1764–1771. doi: 10.1200/JCO.2015.64.5788

Fig 3.

Fig 3.

(A) Pretreatment and (B) posttreatment scans from a patient with anal cancer who had a partial response. The patient was previously treated with neoadjuvant radiotherapy and cisplatin/fluorouracil. There was a 57% reduction in tumor size in cycle 3.